Show Search Form

Search Results

registered interest	true false
date	exactly: or between: and
answering body
answering dept id
answering dept short name
answering dept sort name
hansard heading
house id
legislature	pref label
question text
tabling member constituency
tabling member printed
uin
answer	is ministerial correction true false date of answer exactly: or between: and answer text answering member constituency answering member printed question first answered answering member label attachment file name title
tabling member	label

Search

101568

	registered interest
	date	29/10/2014
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	Ebola
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health, what support and screening facilities his Department has provided for health service volunteers assisting with the Ebola virus crisis in West Africa.
	tabling member constituency	East Londonderry
	tabling member printed	Mr Gregory Campbell
	uin	212400
	answer	answer is ministerial correction date of answer 03/11/2014 answer text <p>The Department of Health is collaborating with a number of Government Departments, Agencies and non-governmental organisation partners to provide support and screening to health service volunteers assisting with the Ebola crisis in West Africa. This work is being managed by the Department for International Development in conjunction with UK Med.</p><p> </p><p> </p><p> </p><p>UK Med run the <em>UK International Emergency Medical</em>, of UK surgeons, anaesthetists, emergency physicians/nurses and other supporting medical, nursing and paramedical staff. They ensure that those who volunteer for this programme of work are appropriately trained, prepared and accountable.</p><p> </p><p> </p><p> </p><p>The programme comprises a robust selection process, pre-deployment preparations and occupational health and psychological screening, training in the United Kingdom with further training and mentoring in Sierra Leone, and advice and support from Public Health England on monitoring health on return.</p><p> </p> answering member constituency Battersea answering member printed Jane Ellison question first answered 03/11/2014 17:33:34 answering member 3918 label Biography information for Jane Ellison
	tabling member	1409 label Biography information for Mr Gregory Campbell

106323

	registered interest
	date	04/11/2014
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	Idiopathic Pulmonary Fibrosis
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health, what steps his Department has taken to act upon the research by the National Institute for Health Research into idiopathic pulmonary fibrosis.
	tabling member constituency	East Londonderry
	tabling member printed	Mr Gregory Campbell
	uin	213429
	answer	answer is ministerial correction date of answer 07/11/2014 answer text <p>The Department’s National Institute for Health Research (NIHR) is funding a systematic review of evidence on the benefits, harms and costs of treatments for idiopathic pulmonary fibrosis (IPF). The report is expected to be published in the journal <em>Health Technology Assessment</em> in January 2015.</p><p> </p><p><strong> </strong></p><p> </p><p>The NIHR Clinical Research Network (CRN) provides support to help the life sciences industry set up and deliver large multi-centre clinical trials in the National Health Service, across a wide range of disease and therapeutic areas. The CRN is currently hosting trials assessing the efficacy and safety of lebrikizumab and simtuzumab in patients with IPF. The CRN is also recruiting patients to a pilot study seeking to test whether omeprazole can reduce cough in patients with IPF.</p><p> </p><p><strong> </strong></p><p> </p><p><strong> </strong></p><p> </p> answering member constituency Mid Norfolk answering member printed George Freeman question first answered 07/11/2014 12:09:02 answering member 4020 label Biography information for George Freeman
	tabling member	1409 label Biography information for Mr Gregory Campbell

155939

	registered interest
	date	17/11/2014
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	Prostate Cancer
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health, following the publication of the results of the ProtecT trial on localised prostate cancer diagnosis, what changes in diagnosis will be introduced for men aged between 50 and 69.
	tabling member constituency	East Londonderry
	tabling member printed	Mr Gregory Campbell
	uin	214793
	answer	answer is ministerial correction date of answer 20/11/2014 answer text <p>As the main aim of the ProtecT trial (Prostate testing for cancer and Treatment) is assessing mortality after 10 year follow-up, the full results of the trial are not expected to be known until 2017. Assessments on the impact of the results on changes to diagnosis will be made based on these results.</p><p> </p> answering member constituency Battersea answering member printed Jane Ellison question first answered 20/11/2014 15:04:00 answering member 3918 label Biography information for Jane Ellison
	tabling member	1409 label Biography information for Mr Gregory Campbell

156592

	registered interest
	date	19/11/2014
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	Cancer
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health, what studies he has commissioned on the potential benefits of using dogs to establish early signs of cancer in humans.
	tabling member constituency	East Londonderry
	tabling member printed	Mr Gregory Campbell
	uin	215220
	answer	answer is ministerial correction date of answer 26/11/2014 answer text <p>A study of key considerations for the experimental training and evaluation of cancer odour detection dogs has recently been published in the journal <em>BMC Urology</em>. The National Institute for Health Research (NIHR) Research Design Service for the East Midlands participated in this study.</p><p> </p> answering member constituency Mid Norfolk answering member printed George Freeman question first answered 26/11/2014 17:20:50 answering member 4020 label Biography information for George Freeman
	tabling member	1409 label Biography information for Mr Gregory Campbell

166007

	registered interest
	date	25/11/2014
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	Prostate Cancer
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health, if he will have discussions with his counterparts in the devolved administrations with the aim of replicating best practice in extending survival rates for men diagnosed with prostate cancer.
	tabling member constituency	East Londonderry
	tabling member printed	Mr Gregory Campbell
	uin	215895
	answer	answer is ministerial correction date of answer 28/11/2014 answer text <p>Research and evidence of best practice in health is shared widely across the United Kingdom. However, as health is a devolved matter Ministers do not routinely discuss health issues with their counterparts.</p><p> </p><p> </p><p> </p><p>The Government’s Mandate to NHS England sets out an ambition to make England one of the most successful countries in Europe at preventing premature deaths from all cancers, including prostate cancer. Cancer indicators in the NHS Outcomes Framework and the Public Health Outcomes Framework will help NHS England to assess progress in improving cancer survival and mortality for men with prostate cancer.</p><p> </p><p> </p><p> </p><p>The National Institute for Health and Care Excellence published an updated clinical guideline on the diagnosis and treatment of prostate cancer in January 2014. To help reduce regional variations, the Care Quality Commission is increasingly incorporating information from accreditation and peer review programmes into its assessments of NHS trusts' services for the treatment of prostate cancer. This includes the national cancer peer review programme and the cancer patient experience survey, both of which encompass prostate cancer.</p><p> </p><p> </p><p> </p><p>The National Prostate Cancer Audit (NCPA) First Year Annual Report was published on the 10 November 2014. The report covers the work undertaken since April 2013. It includes a preliminary analysis of the NPCA’s organisational audit, an analysis of existing data sets including patients with prostate cancer in England, and the design of the NPCA’s prospective audit dataset. The findings from the audit will contribute to changes in clinical practice ensuring that patients receive the best care possible and experience an improved quality of life.</p><p> </p> answering member constituency Battersea answering member printed Jane Ellison question first answered 28/11/2014 13:23:25 answering member 3918 label Biography information for Jane Ellison
	tabling member	1409 label Biography information for Mr Gregory Campbell

168949

	registered interest
	date	09/12/2014
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	NHS: Finance
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health, what the change in total public expenditure on the NHS was in each year between January 2004 and January 2014.
	tabling member constituency	East Londonderry
	tabling member printed	Mr Gregory Campbell
	uin	217993
	answer	answer is ministerial correction date of answer 15/12/2014 answer text <p>It is only possible to provide these figures from the 2007-08 financial year.</p><p> </p><p> </p><p> </p><p>During the Spending Review 2010 period (ie 2011-12 to 2014-15), there have been two significant Machinery of Government changes to transfer functions and spending from the Department of Health to the Department for Communities and Local Government. The spending that related to these function added over £3 billion that would have previously been recorded in the Department of Health’s spending outturn. These changes were only backdated to 2007-08 and therefore no comparable figures are available for financial years before this date.</p><p> </p><p> </p><p> </p><p>The following table summarises the spending outturn against the Department of Health’s total Departmental Expenditure Limit (DEL), for each financial year since 2007-08, and the change over each previous year.</p><p> </p><p> </p><p> </p><p>Spending against total DEL includes NHS commissioners, NHS providers, the Department of Health itself and its arm’s length bodies, including Public Health England and Health Education England.</p><p> </p><p><strong> </strong></p><p> </p><table><tbody><tr><td> </td><td><p>Department of Health total DEL</p></td><td><p>Change</p></td></tr><tr><td> </td><td><p>£ m</p></td><td><p>£ m</p></td></tr><tr><td><p>2007-08</p></td><td><p>84,467</p></td><td><p> </p></td></tr><tr><td><p>2008-09</p></td><td><p>91,040</p></td><td><p>6,572</p></td></tr><tr><td><p>2009-10</p></td><td><p>98,419</p></td><td><p>7,380</p></td></tr><tr><td><p>2010-11</p></td><td><p>100,418</p></td><td><p>1,999</p></td></tr><tr><td><p>2011-12</p></td><td><p>102,844</p></td><td><p>2,426</p></td></tr><tr><td><p>2012-13</p></td><td><p>105,221</p></td><td><p>2,377</p></td></tr><tr><td><p>2013-14</p></td><td><p>109,774</p></td><td><p>4,553</p></td></tr><tr><td><p>2014-15</p></td><td><p>113,035</p></td><td><p>3,261</p></td></tr></tbody></table><p> </p><p><strong> </strong></p><p> </p><p><em>Notes: </em></p><p> </p><ol start="1" type="1"><li>Numbers taken from Department of Health Annual Report and Accounts</li><li>2007-08 to 2013-14 numbers represent the final spending reported in the year-end accounts.</li><li>2014-15 numbers represent the planned spending for this financial year</li></ol><p> </p><p> </p><p> </p> answering member constituency Central Suffolk and North Ipswich answering member printed Dr Daniel Poulter question first answered 15/12/2014 17:43:19 answering member 3932 label Biography information for Dr Dan Poulter
	tabling member	1409 label Biography information for Mr Gregory Campbell

226027

	registered interest
	date	09/03/2015
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	Soft Drinks: Sugar
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health, what the average sugar content in soft drinks was in (a) 2004 and (b) 2014.
	tabling member constituency	East Londonderry
	tabling member printed	Mr Gregory Campbell
	uin	226787
	answer	answer is ministerial correction date of answer 12/03/2015 answer text <p>The Department does not collect this information. However data from the Kantar Worldpanel 2014 dataset show that the sales-weighted average sugar content for soft drinks in 2014 was 4.1 grams per 100 ml. Information is not available for 2004.</p><p> </p><p> </p><p> </p><p>Through our voluntary approach with the food and drink industry, we have cut billions of calories from soft drinks and we have made it easier to see how much sugar is in soft drinks with our colour coded front of pack nutrition labelling.</p><p> </p> answering member constituency Battersea answering member printed Jane Ellison question first answered 12/03/2015 15:56:14 answering member 3918 label Biography information for Jane Ellison
	tabling member	1409 label Biography information for Mr Gregory Campbell

229382

	registered interest
	date	24/03/2015
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	Cancer: Smoking
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health, what his comparative estimate is of the number of deaths due to cancer for which the primary cause was smoking in (a) 2004 and (b) 2014.
	tabling member constituency	East Londonderry
	tabling member printed	Mr Gregory Campbell
	uin	228899
	answer	answer is ministerial correction date of answer 26/03/2015 answer text <p>Time series data showing the estimated number of deaths for adults aged 35 and over that can be attributed to smoking from 2001 to 2013 inclusive is provided in the Health and Social Care Information Centre 2014 Supplementary information files which is available at:</p><p> </p><p> </p><p> </p><p><a href="http://www.hscic.gov.uk/article/5317/2014-Supplementary-information-files" target="_blank">http://www.hscic.gov.uk/article/5317/2014-Supplementary-information-files</a></p><p> </p><p> </p><p> </p><p>2014 mortality data has not yet been published. These data will be released with the forthcoming <em>Statistics on Smoking, England - 2015</em> publication.</p><p> </p><p> </p><p> </p><p>A table providing data from 2003, 2004 and 2013 is attached.</p><p> </p> answering member constituency Battersea answering member printed Jane Ellison question first answered 26/03/2015 11:21:46 answering member 3918 label Biography information for Jane Ellison attachment 1 file name Deaths in adults 35 and over- smoking 2003 2004 & 2013.xlsx title Smoking deaths- adults 35 & over 2003, 2004 & 2013
	tabling member	1409 label Biography information for Mr Gregory Campbell

349621

	registered interest
	date	10/06/2015
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	Cancer: Immunotherapy
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health, if he will take steps to expedite the provision through the NHS of immunotherapy treatments for cancer; and if he will make a statement.
	tabling member constituency	East Londonderry
	tabling member printed	Mr Gregory Campbell
	uin	1825
	answer	answer is ministerial correction date of answer 15/06/2015 answer text <p>A number of immunotherapy drugs are licensed for the treatment of different cancers and are available for use on the National Health Service, subject to funding decisions by the relevant commissioner. Pembrolizumab and nivolumab are two new immunotherapies that are able to treat a number of cancers. The first cancer where these medicines have shown significant increase in patient survival is advanced stage of melanoma. The Medicines and Healthcare products Regulatory Agency has issued early access scientific opinions for both products for treatment of advanced stage melanoma. The Early Access to Medicines scientific opinion for pembrolizumab (Merck Sharp &amp; Dohme) was issued in March 2015 and that for nivolumab (Bristol Myers Squibb) in May 2015.</p><p> </p><p> </p><p> </p><p>Applications for marketing authorisations for both products have already received positive opinions from the European Medicines Agency and marketing authorisations are anticipated to be issued by the European Commission soon.</p><p> </p><p> </p><p> </p><p>Through its technology appraisal programme, the National Institute for Health and Care Excellence (NICE) has been able to recommend a number of immunotherapy treatments including, ipilimumab and obinutuzumab. NICE is currently developing technology appraisal guidance on other immunotherapy treatments including nivolumab and pembrolizumab. Wherever possible, NICE aims to publish draft or final guidance on drugs referred to it within a few months of the drug receiving a license. NHS commissioners are legally required to fund drugs and treatments recommended in NICE technology appraisal guidance.</p><p> </p> answering member constituency Mid Norfolk answering member printed George Freeman question first answered 15/06/2015 13:53:37 answering member 4020 label Biography information for George Freeman
	tabling member	1409 label Biography information for Mr Gregory Campbell

349624

	registered interest
	date	10/06/2015
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	Obesity: Screening
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health, what assessment NHS England has made of the accuracy and effectiveness of the traditional BMI test in determining levels of obesity in adults.
	tabling member constituency	East Londonderry
	tabling member printed	Mr Gregory Campbell
	uin	1828
	answer	answer is ministerial correction date of answer 15/06/2015 answer text <p>NHS England has not made an independent assessment of the accuracy and effectiveness of Body Mass Index (BMI) in determining overweight and obesity in adults.</p><p> </p><p> </p><p> </p><p>Public Health England and NHS England support the implementation of expert guidance on the use of BMI provided by the National Institute for Health and Care Excellence (NICE). Currently, NICE recommends that BMI is used routinely by healthcare professionals to assess obesity in adults and children.</p><p> </p><p> </p><p> </p><p>NICE recommends the use of additional validated obesity measures, such as waist circumference, to be undertaken alongside BMI when assessing overweight and obesity in individuals to give more detailed assessment of an individual’s health risk.</p><p> </p> answering member constituency Battersea answering member printed Jane Ellison question first answered 15/06/2015 11:31:49 answering member 3918 label Biography information for Jane Ellison
	tabling member	1409 label Biography information for Mr Gregory Campbell